Evidence map›Paper›PMID 42750442›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2026

C-low threshold mechanoreceptors: a novel target for health-tech in an increasingly touch-deprived world.

Francis McGlone

Abstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Francis McGloneManchester Metropolitan University , Manchester, UK.ORCID 0000-0002-0881-635X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article describes the putative role of a population of unmyelinated cutaneous nerves that respond optimally to a caressing touch. Massaging touch is of course 'digital', dating back to its use by ancient civilizations for its therapeutic properties, where it was found to promote healing, relieve pain, reduce stress and improve overall well-being. What was then non-verifiable 'alternative medicine' is now verifiable 'touch medicine' with the discovery of a population of cutaneous mechanosensitive c-low threshold mechanoreceptors (C-LTMRs) that preferentially encode gentle dynamic touch, projecting centrally to dorsal posterior insular cortex. They are understood to provide a singular vital protective function across the lifespan, from the nurturing touch of the mother to end-of-life palliative care. Early life touch deprivation causes lifelong adverse neurodevelopmental consequences, with recent evidence finding a potential neuroregenerative and neuroprotective role for C-LTMR stimulation in dementia, brain damage, stress resilience and schizophrenia. By analogy with the vital role vitamins play in physical health, affective touch and its neuronal substrate, the C-LTMRs, can be described as 'vitamin-T' for neurological health. A case is made here for their therapeutic influence in functional neurological disorders. This article is part of the discussion meeting issue 'Digital healthcare for the management of functional neurological disorders'.

Indexed as

MechanoreceptorsTouchAnimalsHumansaffective touchc-tactile afferentsmassageneurodevelopmentstress

Identifiers

PMID42750442
PMCPMC13648195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.